In addition, circ-GALNT16 can inhibit SENP2-mediated hnRNPK de-SUMOylation by binding to the KH3 domain of hnRNPK and inhibit the progression of colorectal cancer [26]. Here, HNRNPK is linked to colorectal cancer.